Cryomass Technologies Ownership
| CRYM Stock | USD 0.02 0.0001 0.55% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Cryomass |
Cryomass OTC Stock Ownership Analysis
About 26.0% of the company shares are held by company insiders. The book value of Cryomass Technologies was currently reported as 0.05. The company recorded a loss per share of 0.08. Cryomass Technologies had not issued any dividends in recent years. The entity had 2:1 split on the 26th of April 2018. Cryomass Technologies Inc. designs, sells, and commercializes cryo-mechanical system for the handling of harvested hemp, cannabis, and other high-value plants. Cryomass Technologies Inc. was incorporated in 2011 and is headquartered in Denver, Colorado. Cryomass Technologies operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.The quote for Cryomass Technologies is listed on Over The Counter exchange (i.e., OTC), and the entity is not required to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges. For more info on Cryomass Technologies please contact Christian Noel at 303 416 7208 or go to https://cryomass.com.Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Cryomass OTC Stock
Cryomass Technologies financial ratios help investors to determine whether Cryomass OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cryomass with respect to the benefits of owning Cryomass Technologies security.